Selected Publications

Arkin LM, Flory JH, Shin DB, Gelfand JM, Treat JR, Allen J, Rubenstein RC, and Yan AC: High Prevalence of Aquagenic Wrinkling of the Palms in Patients with Cystic Fibrosis and Association with Measurable Increases in Transepidermal Water Loss. Pediatric Dermatology Epub ahead of print, April 2012.

Wan J, Abuabara K, Troxel AB, Shin DB, Van Voorhees AS, Bebo BF, Krueger GG, Callis Duffin K, and Gelfand JM: Dermatologist preferences for first-line therapy of moderate-to-severe psoriasis in healthy adult patients. Journal of the American Academy of Dermatology 66(3): 376-386, March 2012.

Wan J*, Vittorio CC*, Abuabara K, Kurd SK, Musiek A, Steinemann JM, and Gelfand JM: A randomized, double-blind, placebo-controlled proof of concept trial of topical 1% and 3% cidofovir for the prevention of beard hair growth in males. Archives of Dermatology 148(2): 257-259, February 2012 Notes: *Co-first authors contributing equally

Wan J, Abuabara K, Shin DB, Troxel AB, Bebo BF, and Gelfand JM: Dermatologist Response Rates to a Mailed Questionnaire: A Randomized Trial of Monetary Incentives. Journal of the American Academy of Dermatology 66(1): e18-20, January 2012.

Raphael BA, Shin DB, Suchin KR, Morrissey KA, Vittorio CC, Kim EJ, Gardner JM, Evans KG, Introcaso CE, Gelfand JM, Rook AH: High clinical response rate of Sézary syndrome with immune modifying therapies: prognostic markers of response. Archives of Dermatology 147(12): 1410-1415, December 2011.

Wan J, Abuabara K, Kurd KK, Musiek A, Steinemann JM, Vittorio CC, and Gelfand JM: Reliability and validity of a photographic method for measuring facial hair density in males. Archives of Dermatology 147(11): 1328-1329, November 2011.

Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, and Gelfand JM: Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom. Journal of Investigative Dermatology Advance Online Publication, November 2011.

Wysocka M, Dawany N, Benoit B, Kossenkov AV, Troxel AB, Gelfand JM, Sell MK, Showe LC, and Rook AH: Synergistic Enhancement of Cellular Immune Responses by the Novel Toll Receptor 7/8 Agonist 3M 007 and Interferon-γ: Implications for Therapy of Cutaneous T-Cell Lymphoma. Leukemia and Lymphoma 52(10): 1970-1979, October 2011.

Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, and Gelfand JM: Systemic and Vascular Inflammation in Patients with Moderate to Severe Psoriasis as measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT): A Pilot Study. Archives of Dermatology 147(9): 1031-1039, September 2011.

Azfar RA, Weinberg JL, Cavric G, Lee-Keltner IA, Bilker WB, Gelfand JM, and Kovarik CL: HIV-positive patients in Botswana state that mobile teledermatology is an acceptable method for receiving dermatology care. Journal of Telemedicine and Telecare 17(6): 338-340, August 2011.